Search results

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.

A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal

We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal

Our forward view highlights the areas we will prioritise in the coming year.

Past technology appraisal appeals and decisions

Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country

Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.

Our quality standards set out priority areas for quality improvement in health, public health and social care.

A timeline showing where in the NICE evaluation process companies will be charged.

A step-by-step summary about how we develop our technology appraisal guidance.

NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country